Pregnancy-Associated Plasma Protein-A Elevation in Patients With Acute Coronary Syndrome and Subsequent Atorvastatin Therapy
- 1 January 2008
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 101 (1) , 35-39
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Pregnancy-associated plasma protein-A levels in patients with acute coronary syndromesJACC, 2005
- Molecular Distinction of Circulating Pregnancy-Associated Plasma Protein A in Myocardial Infarction and PregnancyClinical Chemistry, 2005
- Circulating pregnancy-associated plasma protein A is not an early marker of acute myocardial infarctionClinical Biochemistry, 2004
- Elevated Pregnancy-Associated Plasma Protein-A in Sera from Type 2 Diabetic Patients with Hypercholesterolemia: Associations with Carotid Atherosclerosis and Toe-Brachial IndexThe Journal of Clinical Endocrinology & Metabolism, 2004
- Increased levels of pregnancy-associated plasma protein-A in patients with hypercholesterolemia: the effect of atorvastatin treatmentAmerican Heart Journal, 2003
- Circulating Pregnancy-Associated Plasma Protein A Predicts Outcome in Patients With Acute Coronary Syndrome but No Troponin I ElevationCirculation, 2003
- High-Dose Atorvastatin Enhances the Decline in Inflammatory Markers in Patients With Acute Coronary Syndromes in the MIRACL StudyCirculation, 2003
- Pregnancy-Associated Plasma Protein A as a Marker of Acute Coronary SyndromesNew England Journal of Medicine, 2001
- Effects of Atorvastatin on Early Recurrent Ischemic Events in Acute Coronary SyndromesThe MIRACL Study: A Randomized Controlled TrialJAMA, 2001
- Characterization of four human pregnancy-associated plasma proteinsAmerican Journal of Obstetrics and Gynecology, 1974